QR kȏd

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Introducing neoadjuvant chemotherapy (NCT) in a breast cancer patient may be associated with changes in estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth hormone receptor 2 (HER2) status.

Spremljeno u:
Glavni autori: Taha Heba F., Elfarargy Ola M., Salem Reham A., Mandour Doaa, Salem Amira A., Riad Mohamed
Format: Artigo
Jezik:Inglês
Izdano: Sciendo 2021-05-01
Serija:Forum of Clinical Oncology
Teme:
breast cancer
neoadjuvant chemotherapy
concordance between er
pr
her2 neu
prognosis
Online pristup:https://doi.org/10.2478/fco-2019-0021
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti